Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals-Reference-Cited by-同舟云学术

Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals

Published:2015-07 Issue:7 Volume:37 Page:1564-1571
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Sutherland Christina A.,Nicolau David P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference12 articles.

1. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

2. Infectious Diseases Society of America. 10 x 20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2013

3. ZERBAXA (ceftolozane/tazobactam) for injection, for intravenous use. Initial U.S. approval 2014,2014

4. Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes;Sader;Antimicrob Agents Chemother,2011

5. In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae;Titelman;Diagn Microbiol Infect Dis,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial susceptibility of bacterial clinical specimens isolated from Al-Sader Teaching Hospital in Basra-Iraq;Asia Pacific Journal of Molecular Biology and Biotechnology;2024-03-14

2. Worldwide trend discovery of structural and functional relationship of metallo-β-lactamase for structure-based drug design: A bibliometric evaluation and patent analysis;International Journal of Biological Macromolecules;2024-01

3. Know your enemy: Klebsiella pneumoniae;Molecular Medical Microbiology;2024

4. In Vitro Activity of Ceftolozane-Tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa Obtained from Blood Cultures from Sentinel Public Hospitals in South Africa;Antibiotics;2023-02-24

5. Clinical carbapenem-resistant Klebsiella pneumoniae isolates simultaneously harboring blaNDM-1, blaOXA types and qnrS genes from the Kingdom of Bahrain: Resistance profile and genetic environment;Frontiers in Cellular and Infection Microbiology;2022-10-11